Marc Goodman
Recent Quotes
"We maintain our Buy rating on MRK."
—
Marc Goodman, UBS Securities
(10/23/12)
more >
"MRK remains one of our favorite large cap names."
—
Marc Goodman, UBS Securities
(10/15/12)
more >
"We still really like MRK; we maintain our Buy rating."
—
Marc Goodman, UBS Securities
(9/20/12)
more >
"MRK's vaccines are up 5% YOY driven by Gardasil, Zostavax and other vaccines."
—
Marc Goodman, UBS Securities
(8/30/12)
more >
"We maintain our Buy rating on MRK."
—
Marc Goodman, UBS Securities
(6/4/12)
more >
"We maintain our Buy rating on MRK."
—
Marc Goodman, UBS Securities
(5/29/12)
more >
"MRK's Suvorexant shows positive results in next-day driving performance."
—
Marc Goodman, UBS Securities
(5/11/12)
more >
